Drugs / Dimiracetam
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01444690 | Jan 2012 → Jan 2013 | AIDS | Neurotune AG | Unknown | No outcome recorded |
| Phase 2 | NCT01135251 | Oct 2009 → Mar 2010 | AIDS, neuropathy, painful | Neurotune AG | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dimiracetam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01135251 ↗ |
| Known as | NT-11624 | ChEMBL registry synonym — accepted as the source's own label CHEMBL337612 ↗ |
| Modality | Small molecule | — CHEMBL337612 ↗ |
| Route | Oral | “400 mg capsules for oral use to be administered twice a day for a total of 8 weeks” NCT01135251 ↗ |